BACKGROUND: The views of one's self-stigma and quality of life (QoL) in patients with schizophrenia and depressive disorders are significant subjective notions, both being proven to affect patient's functioning in life. The objective of this study was to investigate the QoL and self-stigma in connection with demographic factors and compare the two groups of patients in terms of those variables. METHODS: In a cross-sectional study, the outpatients with schizophrenia spectrum disorders and depressive disorders completed the Quality of Life Satisfaction and Enjoyment Questionnaire, the Internalized Stigma of Mental Illness Scale, and a demographic questionnaire during a routine psychiatric control. Furthermore, both patients and their psychiatrists evaluated the severity of the disorder by Clinical Global Impression-Severity scale. RESULTS: The QoL of patients with depressive disorders or schizophrenia spectrum disorders did not significantly differ between the two groups. In both groups, unemployment was perceived to be a significant factor decreasing the QoL. Self-stigma was detected to be higher in patients with schizophrenia spectrum disorders than in patients with depressive disorders. A strong correlation was found between the two scales, meaning that those with higher levels of self-stigmatization were less prone to see their life as fulfilling and joyful. CONCLUSION: This study shows that the degree of the internalized stigma can be an important aspect linked to the QoL irrespective of the diagnostic category.

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University Olomouc University Hospital Olomouc Olomouc

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University Olomouc University Hospital Olomouc Olomouc; Department of Psychiatry Hospital Liberec Liberec Czech Republic

Department of Psychology Sciences Faculty of Social Science and Health Care Constantine the Philosopher University in Nitra Nitra Slovak Republic

Zobrazit více v PubMed

Giammanco MD, Gitto L. Coping, uncertainty and health-related quality of life as determinant of anxiety and depression on a sample of hospitalized cardiac patients in southern Italy. Psychol Health Med. 2016;25(11):2941–2956. PubMed

Svoboda M, Češková E, Kučerová H. Psychopatologie a psychiatrie [The Psychopathology and Psychiatry] Praha: Portál; 2006.

Latalova K, Prasko J, Kamaradova D, et al. Self-stigma and suicidality in patients with neurotic spectrum disorder – a cross sectional study. Neuro Endocrinol Lett. 2014;35(6):474–480. PubMed

Rusch N, Zlati A, Black G, Thornicroft G. Does the stigma of mental illness contribute to suicidality. British J Psychiatr. 2014;205(4):257–259. PubMed

Scocco P, Toffol E, Antonio P, SOPRoxi Project Team Psychological distress increases perceived stigma toward attempted suicide among those with a history of past attempted suicide. J Nerv Ment Dis. 2016;204(3):194–202. PubMed

Bengtsson-Tops A, Hansson L. Clinical and social needs of schizophrenic outpatients living in the community: the relationship between needs and subjective quality of life. Soc Psychiatry Psychiatr Epidemiol. 1999;34(10):513–518. PubMed

Hansson L, Sandlund M, Bengtsson-Tops A, et al. The relationship of needs and quality of life in persons with schizophrenia living in the community. A Nordic multicenter study. Nord J Psychiatry. 2003;57(1):5–11. PubMed

Papakostas G, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry. 2004;26(1):13–17. PubMed

Sidlova M, Prasko J, Jelenova D, et al. The quality of life of patients suffer ing from schizophrenia – a comparison with healthy controls. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep. 2011;155(2):173–180. PubMed

Holubova M, Prasko J, Latalova K, et al. Are self-stigma, quality of life, and clinical data interrelated in schizophrenia spectrum patients? A cross-sectional outpatient study. Patient Prefer Adherence. 2016;10:265–274. PubMed PMC

Bowling A. The concept of quality of life in relation to health. Medicina Nei Secoli Arte E Scienza. 1995;7:633–645. PubMed

Latalova K, Prasko J, Diveky T, Kamaradova D, Velartova H. Quality of life in patients with bipolar disorder – a comparison with schizophrenic patients and healthy controls. Psychiatr Danub. 2011;23(1):21–26. PubMed

Holubova M, Prasko J, Hruby R, et al. Coping strategies and self-stigma in patients with schizophrenia-spectrum disorders. Patient Prefer Adherence. 2016;10:1151–1158. PubMed PMC

Latalova K, Kamaradova D, Prasko J. Perspectives on perceived stigma and self-stigma in adult male patients with depression. Neuropsychiatr Dis Treat. 2014;10:1399–1405. PubMed PMC

Ocisková M, Praško J, Kamarádová D, et al. Self-stigma in psychiatric patients – standardization of the ISMI scale. Neuro Endocrinol Lett. 2014;35(7):624–632. PubMed

Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med. 2010;71(12):2150–2161. PubMed

Corrigan PW, Rafacz J, Rüsch N. Examining a progressive model of self-stigma and its impact on people with serious mental illness. Psychiatry Res. 2011;189(3):339–343. PubMed PMC

Tucker JR, Hammer JH, Vogel DL, Bitman RL, Wade NG, Maier EJ. Disentangling self-stigma: are mental illness and help-seeking self-stigmas different? J Couns Psychol. 2013;60(4):520–531. PubMed

Ociskova M, Prasko J, Kamaradova D, Grambal A, Sigmundova Z. Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities. Neuropsychiatr Dis Treat. 2015;11:1767–1779. PubMed PMC

Vrbová K, Kamarádová D, Látalová K, et al. Self-stigma and adherence to medication in patients with psychotic disorders – a cross-sectional study. Neuro Endocrinol Lett. 2014;35(7):645–652. PubMed

Gerlinger G, Hauser M, De Hert M, Lacluyse K, Wampers M, Correll CU. Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact, and interventions. World Psychiatry. 2013;12(2):155–164. PubMed PMC

Kamaradova D, Latalova K, Prasko J, et al. Sebestigmatizace, adherence k léčbě a vysazování medikace u psychických poruch – průřezová studie [Self-stigma, adherence to treatment and withdrawal of medication in psychiatric disorders – a cross-sectional study] Psychiatrie. 2015;19(4):175–183.

Sedlackova Z, Kamaradova D, Prasko J, et al. Treatment adherence and self-stigma in patients with depressive disorder in remission – a cross-sectional study. Neuro Endocrinol Lett. 2015;36(2):171–177. PubMed

Schulze B, Angermeyer MC. Subjective experiences of stigma: a focus group study of schizophrenic patients, their relatives, and mental health professionals. Soc Sci Med. 2003;56(2):299–312. PubMed

Ritsher JB, Phelan JC. Internalized stigma predicts the erosion of morale among psychiatric outpatients. Psychiatry Res. 2004;129(3):257–265. PubMed

Tsang HW, Fung KM, Chung RC. Self-stigma and stages of change as predictors of treatment adherence of individuals with schizophrenia. Psychiatry Res. 2010;180(1):10–15. PubMed

Ociskova M, Prasko J, Vrbova K, Kamaradova D, Jelenova D, Latalova K. Stigma and self-stigma in patients with schizophrenia. Česká Slov Psychiatr. 2014;110(5):250–258.

Uhlmann C, Kaehler J, Harris MS, Unser J, Arolt V, Lencer R. Negative impact of self-stigmatization on attitude toward medication adherence in patients with psychosis. J Psychiatr Pract. 2014;20(5):405–410. PubMed

Kamaradova D, Latalova K, Prasko J, et al. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence. 2016;10:1289–1298. PubMed PMC

Tang IC, Wu HC. Quality of life and self-stigma in individuals with schizophrenia. Psychiatr Q. 2012;83(4):497–507. PubMed

Ociskova M, Prasko J, Kamaradova D, Grambal A, Latalova K, Sigmundova Z. Relationship between internalized stigma and treatment efficacy in mixed neurotic spectrum and depressive disorders. Neuro Endocrinol Lett. 2014;35(8):711–717. PubMed

World Health Organization . The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization; 1993.

Ritsner M, Kurs R, Ratner Y, Gibel A. Condensed version of the Quality of Life Scale for schizophrenia for use in outcome studies. Psychiatry Res. 2005;135(1):65–75. PubMed

Müllerova H. Mezikulturní přenos a validace dotazníku kvality života Q-LES-Q [Transcultural transmission and validation of the life quality questionnaire Q-LES-Q] Psychiatrie. 2001;5:80–87.

Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003;121(1):31–49. PubMed

Boyd JE, Adler EP, Otilingam PG, Peters T. Internalized Stigma of Mental Illness (ISMI) scale: a multinational review. Compr Psychiatry. 2014;55(1):221–231. PubMed

Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville: US DHEW; 1976.

Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med. 2003;33:611–622. PubMed

European Medicines Agency Guideline for Good Clinical Practice ICH. Harmonized Tripartite Guideline. 2003. [Accessed October 28, 2016]. p. 59. Available from: http://www.edctp.org/fileadmin/documents/EMEA_ICH-GCP_Guidelines_July_2002.pdf.

Vrbova K. Sebestigmatizace u pacientů s poruchami schizofrenního spektra. In Czech [Self-stigma in patients with schizophrenia spectrum disorders] Česká Slov Psychiatr. 2016 In press.

Prasko J, Ociskova M, Grambal A, et al. Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder. Neuropsychiatr Dis Treat. 2016;12:2539–2552. PubMed PMC

Hajda M, Kamaradova D, Latalova K, et al. Self-stigma, treatment adherence, and medication discontinuation in patients with bipolar disorders in remission – a cross sectional study. Act Nerv Super Rediviva. 2015;5(1–2):6–11.

Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A. Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients. Neuropsychiatr Dis Treat. 2016;12:1539–1551. PubMed PMC

Ocisková M, Praško J, Látalová K, et al. Internalizované stigma a efektivita farmakoterapie a psychoterapie u úzkostných poruch a poruch neurotického spektra [Internalized stigma and efficacy of pharmacotherapy and psychotherapy in anxiety disorders and neurotic spectrum disorders] Česká Slov Psychiatr. 2014;110(3):133–143.

Górna K, Jaracz K, Wrzyszczyńska L, Rybakowski F. Quality of life and depression in schizophrenic patients. Adv Med Sci. 2007;52(suppl 1):108–111. PubMed

Shargh AB, Rostami B, Kosari B, Zakiye T, Majelan GA. Study of relationship between depression and quality of life in patients with chronic schizophrenia. Global J Health Sci. 2015;8(3):224–229. PubMed PMC

Priebe S, McCabe R, Junghan U, et al. Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time. Schizophr Res. 2011;133(1–3):17–21. PubMed

Quality of life, self-stigma, and coping strategies in patients with neurotic spectrum disorders: a cross-sectional study